Exocrine Pancreatic Insufficiency in Patients with Unresectable Pancreatic Cancer after Symptomatic Surgeries

Ye.A. Kryuchina

Abstract


The aim of study — to investigate the exocrine pancreatic function in patients with unresectable (locally advanced and metastatic) pancreatic cancer after bypass surgery, and evaluate the feasibility, effectiveness and safety of application the replacement high dose enzyme therapy.
Materials and Methods. In the control group of patients (n = 29) in the postoperative period has been administered low-dose enzyme replacement therapy (up to 30,000 U lipase per day), the core group (n = 31) — high-dose enzyme therapy (average 20,000–40,000 U lipase per day). All patients received nutritional support according to the existing protocols, total parenteral nutrition, megestrol acetate or other treatments of pancreatic cachexia are not used. Laboratory measures of nutritional status were serum cholinesterase levels, transferrin, albumin and lymphocyte count. Quality of life was assessed using the EORTC QLQ-C30, exocrine pancreatic function determined by measuring faecal elastase 1 levels. Dynamics of tumor process was evaluated according to the criteria RECIST 1.1. Long-term follow up of patients after surgery (study started 2–3 weeks after surgery) was 16 weeks.
Results and Conclusions. There weren’t deaths due to disease progression or other causes during the study. Side effects associated with the use of enzyme therapy were not observed. It has been proven that high dose enzyme therapy in patients with unresectable pancreatic cancer allows temporarily stop the reduction of body weight, improve the nutritional indices, although not significantly affect the course of disease and quality of life of patients.


Keywords


pancreatic cancer; exocrine pancreatic insufficiency; enzyme therapy

References


Cachexia worsens prognosis in patients with resectable pancreatic cancer / J. Bachmann, M. Heiligensetzer, H. Krakowski-Roosen [et al.] // J. Gastrointest. Surg. — 2008. — Vol. 12, № 7. — P. 1193-1201.

Defect in assimilation following combined radiation and chemotherapy in patients with locally unresectable pancreatic carcinoma / J. Barkin, M. Kalser, S. Thomsen [et al.] // Cancer. — 1982. — Vol. 50, № 10. — P. 2189-2192.

Bauer J. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapya pilot study / J. Bauer, S. Capra // Support Care Cancer. — 2005. — Vol. 13, № 4. — P. 270-274.

Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia / I. Bosaeus // Support Care Cancer. — 2008. — Vol. 16, № 5. — P. 447-451.

Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region / M. Bruno, E. Haverkort, G. Tijssen [et al.] // Gut. — 1998. — Vol. 42, № 1. — P. 92-96.

Fujii M. Effects of chemotherapy with mitomycin C and 5-FU on pancreatic functions in patients with gastric cancer / M. Fujii // Cancer Treat. Rep. — 1980. — Vol. 64, № 10–11. — P. 1151-1152.

Current status of surgery for pancreatic cancer / K. Hirata, S. Egawa, Y. Kimura [et al.] // Dig. Surg. — 2007. — Vol. 24, № 2. — P. 137-147.

Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer / M. Perez, A. Newcomer, C. Moertel [et al.] // Cancer. — 1983. — Vol. 52, № 2. — P. 346-352.

A case of 15 year-old boy with relapsed solid and cystic tumor of the pancreas: pancreatic insufficiency followed by postoperative chemotherapy / T. Shikano, Y. Tabata, Y. Takahashi, M. Anakura // The Journal of the Japan Pediatric Society. — 2002. — Vol. 106, № 4. — Р. 143-146.

Uomo G. Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management / G. Uomo, P. Rabitti // JOP. — 2006. — Vol. 7, № 2. — P. 157-162.

Changes in nutritional status associated with unresectable pancreatic cancer / S. Wigmore, C. Plester, R. Richardson, K. Fearon // Br. J. Cancer. — 1997. — Vol. 75, № 1. — P. 106-109.

Intraoperative radiation enhances decline of pancreatic exocrine function after pancreatic head resection / K. Yamaguchi, K. Nakamura, M. Kimura [et al.] // Journal Digestive Diseases and Sciences. — 2000. — Vol. 45, № 6. — P. 1084-1090.




DOI: https://doi.org/10.22141/1997-2938.1.24.2014.82828

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 UKRAINIAN JOURNAL OF SURGERY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru